What is the CVSS score of CVE-2020-29282?

CVE-2020-29282 has a CVSS 3.1 base score of 9.8 (Critical). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 2.7%.

Is there a public PoC exploit available for CVE-2020-29282?

Yes, a public proof-of-concept exploit is available for CVE-2020-29282. Prioritise patching immediately. EPSS: 2.7%.

Bloodx CVE-2020-29282

CRITICAL

SQL Injection (CWE-89)

2020-12-02 cve@mitre.org

SQLi Bloodx

9.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

9.8 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Dec 02, 2020 - 22:15 nvd

CRITICAL 9.8

DescriptionNVD

SQL injection vulnerability in BloodX 1.0 allows attackers to bypass authentication.

AnalysisAI

SQL injection vulnerability in BloodX 1.0 allows attackers to bypass authentication. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as SQL Injection (CWE-89), which allows attackers to execute arbitrary SQL commands against the database. SQL injection vulnerability in BloodX 1.0 allows attackers to bypass authentication. Affected products include: Bloodx Project Bloodx.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Use parameterized queries/prepared statements. Never concatenate user input into SQL. Apply least-privilege database permissions.